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ABSTRACT 
Poly(ADP-ribose)polymerase-1 (PARP-1) catalyses the 
polymerization of ADP-ribose units from donor NAD+ 
molecules on target proteins, resulting in the attachment of 
linear or branched polymers. The negative charges of 
poly(ADP-ribose) change the target protein affinity for DNA. 
PARP-1 exerts numerous functions in cellular physiology, 
from maintenance of DNA stability and integrity to 
transcriptional regulation and cell cycle control but its role in 
the G0-G1 transition is not yet completely defined.  
The exit from quiescence is a highly regulated and conserved 
process started by extra cellular stimuli. These stimuli, for 
instance serum stimulation, trigger a signal cascade, including 
MAPK activation, that culminates in the transcriptional 
induction of Immediate Early Genes (IEGs). 
Our group has recently reported that PARP-1 activity promotes 
cell cycle re-entry through the induction of a set of IEGs, such 
as c-myc, c-fos, junB and Egr-1.  
On the basis of these previous finding we studied the 
mechanism by which PARP-1 modulates IEGs in fibroblast 
cells. We highlighted  that PARP-1 affects the IEG expression 
at transcription level. Then analyses of chromatin status  of c-
myc promoter evidenced that this region is more condensed in 
absence of poly(ADP-ribosyl)ation upon mitogen stimulation 
of resting fibroblasts. Further, ChIP experiments showed  a 
complex dynamics of PARP-1 binding and chromatin 
poly(ADP-ribosyl)ation at the same region during G0-G1 
transition. Indeed PARP-1 is associated with silent c-myc 
promoter during quiescence but, following mitogen 
  
 
stimulation, activated PARP-1 is displaced from it in 
concomitance with chromatin poly(ADP-ribosyl)ation. These 
PARP-1 activities are associated with the switch of 
transcription factor occupancies on the c-myc promoter. 
Moreover the dynamics of PARP-1 binding at the promoter 
suggested a possible implication of the enzyme in the 
repression of c-myc gene during G0 instauration. According 
with this hypothesis we found that overexpression of PARP-1 
accelerates c-myc shut off during G0 entry. 
Since many early events induced during cell-cycle re-entry are 
shared by different cell lineages in several physiological 
condition, it was investigate whether PARP activity plays a 
role in other cell systems undergoing G0–G1 transition. The 
attention was focused on skeletal myoblasts made quiescent by 
suspension culture. This muscle cell system mimics the 
function of muscle satellite reserve cells and can be activated 
by restoring cell adhesion to substrate. We found that in the 
myoblast context, the inhibition of PARP-1 activity delays the 
induction of proliferation and interfers with both the 
upregulation of IEGs and the expression of the myogenic factor 
MyoD that normally occurs following reserve cell activation. 
This kind of analysis may open new ways of investigation in 
the study of cell cycle exit control that characterize stem cell 
differentiation or quiescence. 
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INTRODUCTION 
G0 phase of cell cycle or quiescence  
Cell cycle consists of four main phases: G1, S, G2, M. G1 
phase corresponds to the interval between mitosis and initiation 
of DNA replication. During G1, the cell is metabolically active 
and continuously grows but does not replicate its DNA. G1 is 
followed by S phase, during which DNA replication takes 
place. The completion of DNA synthesis is followed by the G2 
phase, during which cell growth continues and proteins are 
synthesized in preparation for mitosis. The chromosomes are 
separated in the M phase and the cell divides into two daughter 
cells. G0 phase entry takes place in the G1 phase, before or at 
the restriction point. Quiescence is defined as reversible cell 
cycle arrest where cells are poised to re-enter the cell cycle. In 
an adult organism, most somatic cells (fibroblasts, 
lymphocytes, hepatocytes and adult stem cells) maintain the 
quiescent state for long periods of time. However, in response 
to injury or specific extracellular stimuli, these cells can enter 
the cell cycle and proliferate. In this way, quiescence can be 
distinguished from an irreversibly arrested state such as 
senescence or terminal differentiation. For instance, memory 
lymphocytes are quiescent as they circulate and survey the 
body, and they divide only when stimulated by cognate antigen 
to trigger immune response (Yusuf and Fruman, 2003). 
Similarly, in the skin, dermal fibroblasts are for the most part 
quiescent. Injury to the skin stimulates fibroblasts to rapidly 
proliferate; once tissue repair has been accomplished, the cells 
re-enter G0 phase (Ito et al., 2005). Moreover, satellite cells, 
the muscle stem cells, are quiescent. They are the main 
responsible for postnatal growth and repair of muscle, in fact, 
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in response to various regeneration signals e.g. muscle injury 
or exercise they are activated, express muscle regulatory 
factors and proliferate to initiate the myogenic program. 
However, a small fraction of activated satellite cells down-
regulate myogenic factors, exit the cell cycle and return to the 
quiescent state in order to maintain the self-renewal potential 
(Dhawan and Rando, 2005; Le Grand and Rudnicki, 2007). 
The ubiquity of quiescence as a central feature of cell life 
suggests that its regulation may be critical to normal 
development, degenerative diseases, and cancer. In addition to 
the lack of cell division and 2N DNA content, quiescent cells 
exhibit systematic differences in their metabolism (Bauer et al., 
2004), chromatin organization (Grigoryev et al., 2004) gene 
expression (Coller et al., 2006; Liu et al., 2007) and propensity 
for differentiation. In cultured cells the quiescent state can be 
obtained through growth factor deprivation, contact inhibition, 
or loss of adhesion. Each conditions can induce a shared set of 
genes, indicating the potential existence of a quiescence-
specific transcriptional program (Coller et al., 2006). Several 
tumor suppressor genes, such as Rb, PTEN and cyclin-
dependent kinase inhibitors are required for quiescence 
maintenance (Sage et al., 2003; Groszer et al., 2006). However, 
ectopic expression of CDK inhibitors leads to an irreversible 
senescent-like state and does not recapitulate the transcriptional 
signature of quiescent cells (Coller et al., 2006), which 
suggests that cell cycle arrest and cellular quiescence are not 
functionally equivalent. Sang and colleagues have recently 
reported that reversibility of quiescence is not a passive 
property. Concerning this they have found that expression of 
the gene encoding the basic helix-loop-helix protein HES1 is 
required for the reversibility of quiescence by preventing both 
premature senescence and inappropriate differentiation (Sang 
et al., 2008). 
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The exit from quiescence is a highly regulated and conserved 
process initiated by extra cellular proliferative stimuli. These 
stimuli trigger a complex signal cascade, including MAPK 
pathway, which produces phosphorylation-dependent 
activation of transcription factors and culminates in IEG 
induction (Treisman, 1996). The IEGs encode among others, 
transcription factors belonging to the Myc, Fos and Jun 
families and are characterised by their rapid and transient 
expression in response to extracellular proliferative stimuli 
(Thomson et al., 1999). Is important to note that the 
transcriptional induction of these genes is independent of de 
novo synthesized proteins indicating that the modification of 
pre-existing components of signal transduction cascades are 
responsible for the induction (Greenberg et al., 1986). The 
coordinate transcriptional activation of the IEGs, that initiate 
the G0 exit, can be achieved through general mechanisms such 
as modulation of chromatin structure. Covalent post 
translational modifications of the histone tails and direct 
remodelling of nucleosomes involving ATP-dependent 
complex may explain how chromatin is able to change its 
conformation rapidly according to cell needs. One or specific 
combinations of histone modifications including acetylation, 
phosphorylation, ubiquitination, methylation and ADP-
ribosylation, could affect distinct downstream events by 
altering the structure of the chromatin and/or generating a 
binding platform for protein effectors.  
In particular, acetylation and phosphorylation of histone tails 
are associated with gene expression. Whereas histone 
acetylation is widely connected to transcriptional regulation 
(Grunstein, 1997), phosphorylation of histone H3 at serine 10 
is restricted to the activation of rapidly inducible genes like  the 
IEGs c-fos, c-jun, and c-myc (Thomson et al., 1999).  
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Poly(ADP-ribosyl)ation 
Poly(ADPribosyl)ation is a post-translational modification of 
proteins mediated by a family of enzymes named Poly(ADP-
ribose)polymerases (PARPs). These enzymes initiate the 
reaction by converting the substrate nicotinamide adenine 
dinucleotide (NAD+) to ADP-ribose, and then catalyze ADP-
ribose polymerization on glutamate/aspartate residues of 
acceptor proteins (D’Amours et al., 1999). The resulting 
Poly(ADP-ribose) or PAR consists of a linear or branched 
polyanion of variable size whose monomers are linked to each 
other via  glycosidic ribose-ribose bounds (Figure I). 
PAR can act as a site-specific covalent modification or as a 
protein-binding matrix that recruits specific factors. In fact, 
attachment of PAR is thought to alter the activity of target 
proteins through both steric and charge effects, ultimately 
preventing protein-protein interactions, protein-nucleic acid 
interactions, enzymatic activity, or subcellular localization 
(Schreiber et al., 2006; Hassa and Hottiger, 2008). 
The catabolism of PAR in the cell is regulated mainly by a 
specific exo-/endo-glycohydrolase (PARG), which catalyzes 
the hydrolysis of PAR into free ADP-ribose and thus controls 
the level of poly(ADPribosyl)ated proteins. Furthermore, 
(ADP-ribosyl)proteinlyase cleaves the final remaining ADP-
ribose monomer from the target protein.  
PARP activity has been found in a vast variety of organisms 
raging from archaebacteria to mammals but it is absent in yeast 
(Hassa et al., 2006; Rolli et al., 2000). To date, 17 members of 
PARP superfamily have been identified in mammalian 
genome. They have different structural domains and functions 
but all share a PARP signature motif that forms the active site 
(Amè et al., 2004). Recently, Hottiger and colleages (Hottiger 
et al., 2010) have proposed a new structure-based classification 
of PARP family members based on their catalytic domains: 
PARPs 1-5, which are bona fide PARPs containing a conserved 
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glutamate (Glu 988 in PARP-1) that defines the PARP catalytic 
activity; PARPs 6–8, 10–12, and 14–16, which are confirmed 
or putative momo(ADP-ribosyl)transferase; and PARPs 9 and 
13, which lack key NAD+-binding residues and the catalytic 
glutamate, and are likely inactive (Kleine et al., 2008). 
 
 
 
 
 
  
Figure I: Chemical structures of NAD+, nicotinamide (NAm), and 
PAR. PAR is a branched polymer synthesized on acceptor proteins by 
PARPs using NAD+ as a donor of ADP-ribose units. The ADP-ribose units in 
the linear PAR chains are linked by 1″ → 2′ ribose-ribose glycosidic bonds 
whereas the ADP-ribose units at the branchpoints are linked by 1″′ → 2″ 
ribose-ribose glycosidic bonds (adapted from Kim et al., 2005). 
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Structure of PARP-1 enzyme 
Poly(ADP-ribose)polymerase-1 (PARP-1) is a ubiquitous and 
abundant enzyme as well the most studied member of PARP 
family. Known targets of PARP-1 catalytic activity include 
PARP itself histones (especially H1, H2A, and H2B) 
transcription factors, nuclear enzymes, DNA repair proteins 
and nuclear structural proteins. (D’Amours et al., 1999; Kim et 
al., 2005). 
PARP-1 has a highly conserved structural and functional 
organization (Figure II). It is composed of three main domains: 
an N-terminal DNA-binding domain (DBD), a central 
automodification domain, and a C-terminal catalytic domain 
(D’Amours et al., 1999; Rolli et al., 2000).  
 
 
 
 
 
Figure II : Schematic representation of PARP-1's structural and functional 
organization. The DBD domain, the automodification domain with BRCT motif and 
the catalytic domain of PARP-1 are represented (adapted from Kraus, 2008). 
 
 
The DBD contains two Cys-Cys-His-Cys zinc fingers (FI/Zn1 
and FII/Zn2) responsible for the  binding to DNA, a nuclear 
localization signal (NLS), a caspase-3 cleavage site, and a third 
zinc binding domain (FIII/Zn3) that mediates inter-domain 
contacts important for DNA-dependent enzyme activation 
(Langelier et al., 2008). PARP zinc fingers are structurally and 
functionally unique, since they can recognize altered structures 
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in DNA including single and double strand breaks, crossover 
and cruciforms rather than particular sequences.  
The automodification domain of PARP-1 is located in the 
central region of the enzyme, between residues 374 and 525 
(human protein) (Kurosaki et al., 1987). This domain is rich in 
glutamic acid residues, consistent with the fact that poly(ADP-
ribosyl)ation occurs on such residues. Although automodified 
PARP-1 loses its activity (D’Amours et al., 1999), it gains the 
ability to bind proteins through conserved PAR-binding 
domains in a non-covalent manner (Pleschke et al., 2000; 
Karras et al., 2005). This domain also contains a protein-
protein interaction module called BRCT (breast cancer 1 
protein C-terminus motif) that is present in many DNA damage 
repair and cell-cycle checkpoint proteins.  
The catalytic domain is located in the C-terminal part of the 
enzyme and, in human PARP-1, spans residues 526-1014. The 
CD is the most conserved domain across the PARP family and 
contains the PARP signature motif which binds NAD+. X-ray 
diffraction of this domain showed that the NAD+ binding site 
consists of a β-α-loop-β-α structural motif (Ruf et al., 1998). 
This catalytic domain catalyzes multiple distinct reactions in 
the PAR synthesis: 1) attachment of the first ADP-ribose 
moiety on acceptor protein; 2) elongation of PAR and 3) 
branching of PAR (D’Amours et al., 1999). Together, the 
structural and functional domains of PARP-1 confer the 
activities required for the broad range of functions of PARP-1 
in the nucleus. Although PARP-1 was originally characterized 
as a key sensor of DNA damage, more recent studies have 
linked the enzyme to the regulation of chromatin structure and 
transcription, DNA methylation and imprinting, insulator 
activity, and chromosome organization.  
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Regulation of PARP-1 activity 
PARP-1’s basal enzymatic activity is very low, but is 
stimulated by a variety of allosteric activators, including 
damaged DNA, some undamaged DNA structures, 
nucleosomes, and a variety of protein-binding partners 
(D’Amours et al., 1999; Kraus, 2008).  
PARP-1 was originally characterized as a DNA damage sensor, 
since its catalytic activity is strongly stimulated by binding 
with single and double-strand breaks. PARP-1 has been 
implicated in multiple DNA repair pathways, including single 
strand breaks (SSB), double strand breaks (DSB), and base 
excision repair (BER) pathways (Dantzer et al., 1999). The 
PAR production after DNA damage recognition leads to 
chromatin loosening and so increase the access to breaks of 
repair proteins. Several additional stimuli for PARP-1 
activation, in absence of DNA damage, have been identified. 
First, a fast activation of PAR synthesis is evoked upon heat or 
steroid hormone exposure, in Drosophila. This PARP activity 
is required for normal chromatin puffing, chromatin loosening 
at polytene chromosomes, and gene expression (Tulin and 
Spradling, 2003). Second, It has been reported that the PARP-
1, included as a component of a transcriptional co-regulator 
complex, is activated downstream the PDGF-induction of a 
specific calcium-dependent protein Kinase pathway, in 
proliferating neuronal progenitors (Ju et al., 2004). Moreover, a 
previous work from our laboratory has reported PARP-1 
activation upon serum stimulation of resting cells highlighting 
an important role of this enzyme in the cell cycle reactivation 
of quiescent cells (Carbone et al., 2008).  
A number of molecular mechanisms for  PARP-1 activation 
have been elucidated. For example poly(ADP-ribosyl)ation has 
been shown to be induced downstream of the Extracellular-
Signal Regulated Kinases (ERK) cascade signalling trough the 
direct interaction of the enzyme with the phosphorylated form 
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of ERK-2 (Cohen-Armon et al., 2007). Then PARP-1 could be 
recruited to specific genes and activated by interaction with 
DNA binding factors as in the case of the transcription factor 
YY1 which binds to the BRCT motif of PARP-1 and stimulates 
PARP activity (Griesenbeck et al., 1999). In previous studies 
conducted in our laboratory, it has been demonstrated that the 
interaction between PARP-1 and structural viral proteins can 
activate poly(ADP-ribosyl)ation and that this PAR synthesis is 
used for efficient viral infection (Carbone et al., 2006). 
PARP-1 catalytic activity is also regulated by post translational 
modifications. These include poly(ADP-ribosyl)ation, 
phosphorylation, acetylation, ubiquitylation, and 
SUMOylation; (reviewed by Krishnakumar and Kraus 2010b).  
Automodification of PARP-1, may occur as an extensive 
addition of ADP-ribose in chains >200 units in length or as a 
more modest addition of a single unit or chains up to 20 units 
in length (D’Amours et al., 1999; Mendoza-Alvarez and 
Alvarez-Gonzalez, 1999). Extensive automodification of 
PARP-1, which occurs for example in response to DNA 
damage, inhibits its DNA-binding and catalytic activities 
(D’Amours et al., 1999). Phosphorylation by ERK1/2 or JNK1 
enhances its catalytic activity (Kauppinen et al., 2006; Zhang et 
al., 2007). The former is needed to maximize PARP-1 
activation after DNA damage in neurons and astrocytes, 
whereas the latter promotes sustained PARP-1 activation 
during hydrogen peroxide-induced non apoptotic cell death 
PARP-1 is acetylated by the acetyltransferases p300/CBP and 
PCAF (Hassa et al., 2003, 2005; Rajamohan et al., 2009). 
Acetylation of PARP-1 was first identified in the context of 
NF-kBdependent transcription in immune cells, where it plays 
a critical role in regulating NF-kB target genes (Hassa et al., 
2003, 2005). In cardiomyocytes, PARP-1 is acetylated as an 
endpoint of stress responses, resulting in the DNA damage-
independent activation of PARP-1 (Rajamohan et al., 2009). 
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PARP-1 and transcription 
In addition to the well-established role in DNA damage repair, 
growing amounts of evidence have demonstrated a role for 
PARP-1 in transcriptional regulation in response to biological, 
chemical or physical stimuli. Recently chromatin 
immunoprecipitation coupled to hybridization to genomic 
microarrays (i.e. ChIP-chip) has shown that PARP-1 binding is 
enriched at the promoters of expressed RNA polymerase II-
transcribed promoters in MCF-7 cells (Krishnakumar et al., 
2008). However, this does not imply necessarily a stimulatory 
role for PARP-1 at all of these promoters, but rather indicates 
that PARP-1 localizes to sites of ongoing transcription, 
exerting stimulatory or inhibitory effects (Krishnakumar et al., 
2008). Moreover, in a study exploring gene expression profiles 
in embryonic stem cells and livers from Parp-1-/- mice, 3.5% 
of the transcriptome was regulated by PARP-1, with 
approximately 60–70% of the genes being positively regulated 
(Ogino et al., 2007). This regulation can be achieved through 
different mechanisms (Figure III). 
a) Opening of the chromatin structure by the removal of 
histones after their poly(ADP-ribosyl)ation, as it occurs at 
DNA breaks (Schreiber et al., 2006). First of all, PARP-1 acts 
to exclude H1 from the promoters of some PARP-1-regulated 
genes, possibly by competing with H1 for binding to 
nucleosomes or by poly(ADP-ribosyl)ating it (Krishnakumar et 
al., 2008). For example, this PAR-mediated chromatin 
loosening is observed at larval salivary-gland polytene-
chromosome puffs (Tulin & Spradling, 2003). It has been 
proposed a model by which PARP-1 can direct the reversible 
modulation of chromatin structures. Using in vitro approaches 
they have found that PARP-1, acting like H1, incorporates into 
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chromatin and promotes the formation of compact, 
transcriptionally repressed structure. In the presence of NAD+ 
the enzyme automodifies and dissociates from chromatin 
resulting in the formation of decondensed transcriptionally 
active chromatin structures (Kim et al., 2004). Moreover, 
during estrogen-induced transcription of the TFF1 gene, 
PARP-1 not only promotes the removal of H1 but also 
increases the levels of HMGB1, a chromatin architectural 
protein that enhances transcription (Ju et al., 2006). It has been 
recently reported that PARP-1 poly(ADP-ribosyl)ates 
Drosophila ISWI, an ATP-dependent nucleosome remodeller 
associated with chromatin compaction, and that this 
modification is involved in the induction of hsp70 gene upon 
heat shock (Sala et al., 2008). More recently, it has been shown 
that PARP-1 leads to a transcription permissive chromatin 
environment by preventing demethylation of H3K4me3 
through the poly(ADP-ribosyl)ation, inhibition, and exclusion 
of the histone demethylase KDM5B (Krishnakumar and Kraus, 
2010a). 
b) Many of the initial studies describing direct effects of 
PARP-1 on the transcriptional regulation of target genes 
focused on the binding of PARP-1 to specific DNA sequences 
or structures in the regulatory regions of the genes. In these 
cases, PARP-1 functions like a classical enhancer-binding 
factor (Kraus, 2008). For example, it has been examined the 
role of PARP-1 in the regulation of CXCL1 (Amiri et al., 
2006) and BCL6 (Ambrose et al., 2007) genes. PARP-1 binds 
to specific sequences immediately upstream of the CXCL1 
promoter and in the first intron of BCL6 to repress 
transcription. For CXCL1, PARP-1 prevents the binding of 
NF-κB to an adjacent element, an effect that is reversed upon 
PARP-1 activation and automodification, that results in a loss 
of PARP-1 binding to the promoter. 
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 c) PARP-1 has been found to interact with different 
transcriptional regulators (Schreiber et al., 2006), such as 
nuclear receptors, NF-κB, HES1, B-Myb, Oct-1, HTLV Tax-1, 
Sp1, NFAT, Elk1, and others. In most of these cases, the DNA-
binding factor is thought to recruit PARP-1 to relevant target 
 
 
 
Figure III. Multiple modes of transcriptional regulation by PARP-
1. PARP-1 regulates transcription in perhaps as many as four modes, as 
indicated. (a) PARP-1 can modulate chromatin structure by binding to 
nucleosomes, modifying histone proteins, or regulating the composition of 
chromatin. (b) PARP-1 can act as an enhancer-binding factor that functions 
in a manner similar to classical sequence-specific DNA-binding activators or 
repressors. In this mode, PARP-1 may bind to specific sequences or 
structures in the DNA. (c) PARP-1 can function as a transcriptional 
coregulator in a manner similar to classical coactivators and corepressors. In 
this mode, PARP-1 may function as a promoter-specific "exchange factor" 
that promotes the release of inhibitory factors and the recruitment of 
stimulatory factors during signal-regulated transcriptional responses. TF, 
DNA-binding transcription factor (d) PARP-1 can function as a component of 
insulators, which act to limit the effects of enhancers on promoters or by 
preventing the spread of heterochromatin. In this mode, the PARylation of 
CTCF by PARP-1 is likely to play a role in the maintenance of insulator 
function. (from Kraus, 2008) 
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promoters. In some cases, PARP-1 enzymatic activity is not 
required for its co-regulatory activity (e.g. with NF-κB, B-
Myb, and HTLV Tax-1). Otherwise, the DNA-binding factor 
or other components of the co-regulatory complex are targets 
for PARP-1-dependent poly(ADP-ribosyl)ation. A key 
question regarding PARP-1 co-regulatory activity is the effect 
that it has on the transcription complexes assembled at target 
promoters. Recent studies have shown that PARP-1 can 
function as a promoter-specific ‘exchange factor’ that promotes 
the release of inhibitory factors and the recruitment of 
stimulatory factors during signal-regulated transcriptional 
responses (Ju et al., 2004; Pavri et al., 2005). More recently, 
PARP-1 was shown to promote the recruitment of 
topoisomerase IIβ (TopoIIβ) to hormone-regulated promoters, 
leading to concomitant promoter DNA cleavage, factor 
exchange, and transcriptional activation (Ju et al., 2006). 
d) Last, recent studies have implicated PARP-1-dependent 
poly(ADP-ribosyl)ation of CTCF, a ubiquitous DNA-binding 
protein that functions at insulators, in the preservation of 
insulator function. Insulators are DNA elements that help to 
organize the genome into discrete regulatory units by limiting 
the effects of enhancers on promoters or by preventing the 
spread of heterochromatin (Yu et al., 2004).  
Together, these studies highlight the diverse and probably non-
exclusive mechanisms of PARP-1 co-regulator function, which 
are likely to vary in an activator-specific and gene-specific 
manner. 
 
Previous results and aims of the work 
Poly(ADP-ribosyl)ation has been implicated in several distinct 
processes regulating chromatin structure and transcriptional 
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activity. PARP-1, the major member of the PARP family, 
functions both as a structural component of the chromatin and 
as a modulator of chromatin function, in part through its ability 
to poly(ADP-ribosyl)ate histone proteins and transcription 
regulators. This enzyme is recognised to be important in many 
other cellular functions such as chromosome stability, cell 
cycle and apoptosis.  
In our laboratory it was demonstrated that PARP-1 is involved 
in the fibroblasts exit  from G0 phase. We showed that 
increased poly(ADP-ribosyl)ation, mainly involving the 
activation of PARP-1, is transiently detectable within 15 min 
after serum stimulation of quiescent fibroblasts. 
The functional importance of the prompt PARP activation in 
quiescent cells stimulated with serum was first suggested by 
the observation that PARP inhibitors interfere with the ability 
of these cells to re-enter cell cycle. PJ-34 treatment causes a 
dose-dependent interference with cell cycle reactivation, which 
correlates with a dose-dependent inhibition of PARP activity.  
Analysis of the early phases of the response to serum 
stimulation revealed that PARP activation correlates with and 
is required for the timely up-regulation of IEGs and that this 
regulation occurs at RNA level. We confirmed also, using a 
specific immunoprecipitation, that PARP-1 is responsible of 
the most cellular poly(ADP-ribosyl)ating activity during the 
early response. Moreover, using small interfering RNA, we 
showed that PARP-1 is the PARP family member playing the 
most prominent role in IEGs activation (Carbone et al., 2008). 
Collectively all these previous data provide a functional link 
between PARP-1 activation and fibroblast cell cycle re-entry. 
On the basis of these findings the work reported in  the present 
thesis aims to investigate the molecular mechanism by which 
PARP-1 regulates the expression of IEGs.  
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To this end we studied the involvement of PARP activity in the 
accessibility and transcription factors binding to c-myc 
promoter by performing DNase accessibility and ChIP assays. 
Then we analysed the IEG induction during G0-G1 transition 
in PARP-1 knock-down cells and the effect of PARP-1 
exogenous expression on c-myc shut off during quiescence 
establishment. 
The proper regulation of the quiescent state it is implicated in 
controlling differentiation, preserving stem cells function and 
preventing tumorigenesis. Indeed, it is critical for tissue 
homeostasis. The reversible transitions between quiescence and 
proliferation are accompanied by rapid changes of the 
transcription programs, resulting in the activation or repression 
of specific genes involved in cell growth and differentiation. 
The possible implication of PARP-1 activity in other cell 
systems undergoing G0–G1 transition was studied in reserve 
cells which mimic the skeletal muscle stem cells. These cells 
are able to proliferate and undergo myogenic differentiation or 
return in a quiescent undifferentiated state. We investigated the 
effects of PARP inhibition and PARP-1 silencing in the 
reactivation of reserve cells which is characterized by IEGs 
upregulation  as well as by the induction of the myogenic 
factor myoD.   
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RESULTS 
PARP-1 regulates early response genes in serum-stimulated 
fibroblasts at the RNA level  
It has been previously demonstrated that PARP-1 activity is 
involved in the fibroblasts exit from a quiescent state. This is a 
multistep process that begins with the immediate early 
response to mitogens and extends into an early G1 phase. 
PARP-1 activity is involved in this step through the regulation 
of IEGs (Carbone et al., 2008). 
To directly verify whether PARP-1 affects the expression of 
IEGs at the RNA level, we analysed the effects of its knock-
down on the kinetics of IEGs induction. Therefore, mouse 
fibroblasts were serum-starved for 36 h to induce the quiescent 
state and then transfected with a specific small interfering RNA 
(siRNA) designed to reduce PARP-1 expression or a control 
siRNA. After 48 h, cell cycle reactivation was stimulated 
through serum addition. The silencing of PARP-1 was assessed 
by western blot. Total RNA was extracted at different times 
from stimulation and the induction of the IEGs c-myc, c-fos 
and junB was analysed with RT-qPCR. The plots reported in 
Figure 1 show that the specific knock-down of PARP-1 is 
associated with a significant reduction of c-myc, c-fos and 
junB upregulation respect to the control cells. These results 
confirm that PARP-1 is required for the correct induction of 
IEGs during quiescence exit playing a role at the RNA level, 
likely through transcription regulation. 
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Figure 1.  PARP-1 knock-down affects IEGs  serum induced up-
regulation  
 Quiescent mouse embryo fibroblasts were transfected with siRNA specific 
for PARP-1 (red lines) or nonspecific control siRNA (blue lines). RNA levels 
were quantized  by RT-qPCR. Forty-eight hours later, the cells were 
stimulated by adding 10% fetal bovine serum and lysed at the indicated 
times for RNA extraction. 
A-C) RNA levels of c-myc, c-fos, junB  were expressed as fold increase 
respect to control T0 (quiescent)  samples.;  min p.s.a  on horizontal  axes  
means minutes post serum stimulation and the error bars represent the SEM 
of three replicates. 
D) The PARP-1 mRNA levels were analyzed to confirm the silencing 
efficiency.  
 
A 
B D 
C 
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PARP activity changes c-myc promoter accessibility during 
G0-G1 transition 
According to the role of PARP-1 in modulating chromatin 
structure and function, we examined the effects of PARP 
inhibition on the status of c-myc promoter through DNAseI 
accessibility assays. Three regulated DNAse I-hypersensitive 
sites have been mapped upstream the c -myc gene, in a region 
that overlaps P1 and P2 c-myc promoters (Figure 2 A). The 
intensity of cleavage at these sites parallels the synthesis of c-
myc mRNA (Levens et al., 1997; Wierstra and Alves 2008).  
For the experiment, fibroblasts were made quiescent by serum 
starvation and then the IEG response was induced by serum 
stimulation. To inhibit PARP activity, PJ-34 (a competitive 
inhibitor) was added at the same time as serum. Next entire 
nuclei, isolated from quiescent and serum-stimulated cells, 
were treated with DNAseI at increasing concentrations. Then 
DNA was purified and quantified. A same amount of template 
was used in PCR assays to assess the extent of DNAseI 
digestion. A primer set specific for the P1/P2 promoter region, 
that contains the hypersensitive sites, was used. In this way the 
amount of PCR product reflected the resistance to DNAseI 
digestion.  
As expected, serum stimulation caused a significant decrease in 
the DNAseI resistance respect to quiescent cells. This 
suggested an increase in accessibility or chromatin de-
condensation according with the induction of the gene. 
Remarkably, cells stimulated in presence of the PARP inhibitor 
showed a degree of DNAseI resistance higher than non-treated 
control cells, and similar to quiescent cells (Figure 2 B). Thus 
the inhibition of PARP activity prevents the increase in DNA 
digestion associated to the transcription of c-myc gene. The 
results are consistent with a model in which 
poly(ADPribosyl)ation participates in the IEGs activation 
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modulating the accessibility of promoters to transcription 
factors. 
 
 
                        
 
               
Figure 2   PARP activity modulates DNAseI accessibility at c-
myc promoter. 
A) Schematic representation of nucleosomal  structure of inactive and active 
c-myc promoter. Shown are the promoters P1 and P2, the  DNAse I-
hypersensitive sites (HS) and the primer set used in the subsequent assay. 
The HS were only present on active c-myc gene (adapted from Wierstra and 
Alves, 2008 ). 
B) DNAse I accessibility assays were performed on quiescent and serum 
stimulated human fibroblasts in the presence or absence of PARP-1 inhibitor 
PJ-34. The entire nuclei were isolated from quiescent cells (0) and 15 
minutes (15) post serum addition and  then treated with increasing quantities 
of DNaseI (0-100 units). Semi-quantitative PCR shows the different amounts 
of the fragments after DNAseI digestion. Min p.s.a stand for  minutes post 
serum stimulation. 
A 
B 
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PARP activity influences transcription factors binding to c-
myc promoter 
Since we demonstrated the implication of PARP activity in c-
myc promoters compaction, we investigated if poly(ADP-
ribosyl)ation can influence also transcription factors exchange. 
To this aim chromatin immunoprecipitation assays (ChIP) were 
performed in quiescent and in serum stimulated fibroblasts in 
the presence or absence of the PARP inhibitor PJ-34. Then the 
occupancy of c-myc promoter region by transcription factors 
was analyzed by using PCR amplification with specific 
primers. Among all proteins that are known to modulate c-myc 
expression we focused our attention on Sp1 and CTCF. Both 
proteins are targets of poly(ADP-ribosyl)ation (Zaniolo et al., 
2007; Yu et al., 2004) and can bind to specific sequences in the 
same region analysed for DNAseI accessibility, the c-myc 
P1/P2 promoter region (Chernukhin et al., 2000; Filippova et 
al., 1996; Klenova et al., 1993). In particular Sp1 has a positive 
effect on c-myc transcription (Majello et al., 1995) whereas 
CTCF is known to represse it (Filippova et al., 1996).  
As reported in Figure 3, ChIP experiments showed that c-myc 
promoter was not occupied by Sp1 in quiescent cells but the 
induction of c-myc transcription by serum stimulation resulted 
in the SP1 binding to the promoter, according to its 
involvement in mitogen-dependent c-myc induction. 
Interestingly the association of Sp1 with the promoter was 
prevented in PJ-34 treated cells (i.e in absence of PARP 
activation). On the other side, the c-myc repressor CTCF 
bound to the promoter during the quiescent state, but was 
released 15 min after serum stimulation, consistent with the 
activation of c-myc gene expression. Interestingly, when PARP 
activity was inhibited by PJ-34, CTCF remained associated 
with the promoter despite serum addition. All these evidences 
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indicate that the dynamics of poly(ADP-ribose) synthesis is 
associated with change in transcription factors binding to c-
myc promoter.  
                         
   
                  
Figure 3.  Poly(ADP-ribosyl)ation influences the transcription factor 
exchange at c-myc promoter. 
A) Schematic representation of Sp1 and CTCF binding sequences on c-myc 
promoter. Primers used in the ChIP assays are reported. 
B) Sp1 and CTCF ChIP assays. Quiescent and activated fibroblasts, in the 
presence or absence of PJ-34, were fixed at the indicated minutes post 
serum addition. Sonicated chromatin from these samples was 
immunoprecipitated with an antibody to Sp1 (upper panel) or to CTCF (lower 
panel). Then DNA extracted from the immunoprecipitated fractions was 
amplified by PCR with primers specific for the region between P1 and P2. 
PCR analyses show the desired-size products. DNA sample lane 
A 
B 
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descriptions are as follows; Input: samples isolated from cell lysates prior to 
antibody pull down as an internal positive control; No Ab: samples isolated 
after pull down with no antibody; Sp1: samples isolated after Sp1 
immunoprecipitation; CTCF: samples isolated after CTCF 
immunoprecipitation). 
 
PARP-1 binds to and modifies c-myc promoter  
To test a direct implication for PARP-1 in chromatin 
remodeling and transcription factor exchange at c-myc 
promoter, ChIP assays were performed. Chromatin samples 
from proliferating, quiescent, and serum stimulated cells in the 
presence or absence of PJ-34, were  immunoprecititated using 
antibodies directed against PARP-1 or its  enzymatic product 
PAR. The presence of c-myc promoter sequences in the  
immunoprecipitated chromatin fractions was analysed by PCR 
with primers specific for the region between P1 and P2. 
Remarkably, as shown in figure 4, PARP-1 was associated 
with silent c-myc promoter in quiescent cells but not in 
proliferating cells when the gene was expressed at a basal 
level. Moreover, following serum stimulation of quiescent 
cells, PARP-1 was displaced from c-myc promoter in 
concomitance with chromatin poly(ADP-ribosyl)ation of the 
same region, probably due to PARP-1 specific activity. 
According to this hypothesis, in cells stimulated in the presence 
of PJ-34, poly(ADP-ribosy)lation was impaired and PARP-1 
continued to occupy c-myc promoter (Figure 4). These results 
indicate that during the reversible transitions between 
quiescence and proliferation the enzyme interacts in a complex 
and dynamic manner with cell cycle-controlling genes, at least 
in part through its ability to poly(ADP-ribosyl)ate chromatin.  
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Figure 4. PARP-1 binds to c-myc promoter in G0 cells and is released 
in concomitance with poly(ADP-ribosyl)ation of the promoter. 
PARP-1 and PAR chromatin immunoprecipitation. Quiescent fibroblasts 
were stimulated to re-enter the cell cycle by serum in the presence or  the 
absence of PJ-34.  Then they were fixed at the indicated minutes post serum 
addition. Sonicated chromatin from these samples was immunoprecipitated 
with an antibody  to PARP-1 (upper panel) or to PAR (lower panel). Then 
DNA extracted from the immunoprecipitated fractions was amplified by PCR 
with primers specific for the region between P1 and P2 c-myc promoters. 
PCR analyses show the desired-size products. DNA sample lane 
descriptions are as follows. Input: samples isolated from cell lysates prior to 
antibody pull down as an internal positive control; No Ab: samples isolated 
after pull down with no antibody represent the aspecific bounded DNA; 
PARP-1: samples isolated after PARP-1 immunoprecipitation; PAR: samples 
isolated after polyADP-ribose immunoprecipitation. 
Different mechanism of regulation between c-myc and c-fos 
The finding that PARP-1 binds to c-myc promoter during the 
quiescent state prompted us to study the effect of the enzyme 
silencing at different times in relation to growth arrest. To this 
aim PARP-1 was knocked-down in proliferating fibroblasts 
with a specific siRNA and subsequently these cells were 
serum-starved. After 48 h, cell cycle re-entry was stimulated by 
serum addition. Total RNA was extracted from quiescent and 
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serum-stimulated cells. Then the induction levels of the IEGs 
c-myc and c-fos were analysed with RT-qPCR. Surprisingly 
PARP-1 knock-down, performed before cell cycle exit, had 
different effects on the two IEGs. Indeed c-myc induction was 
not significantly influenced by PARP-1 silencing compared to 
the control (Figure 5B), while c-fos was affected (Figure 5C), 
suggesting some differences between PARP-1-dependent 
regulation of c-fos and c-myc gene expression. 
 
            
Figure 5.  PARP-1 silencing before quiescence entry has a 
different effect on c-fos and c-myc up-regulation. 
 (A-C) RT-qPCR quantization of PARP-1 and IEGs mRNA levels. 
Proliferating MEF fibroblasts were transfected with siRNA specific for PARP-
1 (red lines) or control siRNA (blue lines). Then, the cells were  growth 
arrested by serum withdrawal. RNA samples  were prepared after serum-
stimulation to G0-G1 transition of cells. The Horizontal axis values represent 
the minutes post serum stimulation (min p.s.a.). The vertical axis values 
represent the expression fold change respect to control T0 sample, RNA 
levels of parp-1 c-myc, c-fos, were normalized on 18S. The error bars 
represent the SEM of three replicates.  
C 
A B 
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Because of these differences, the binding of PARP-1 to the c-
fos promoter was investigated by performing ChIP assays. 
Chromatin samples were prepared from quiescent cells and at 
different times from serum stimulation. The presence of c-fos 
promoter sequences in the fraction of PARP-1 bound 
chromatin was detected using primers specific for a promoter 
region encompassed between the serum responsive element 
and the transcription start site. PARP-1 bound to this region 
from 15 to 45 min after serum stimulation but not in 
quiescence. Therefore, differently from what happens for c-
myc promoter that is bound by PARP-1 in quiescent cells, 
PARP-1 does not occupy c-fos promoter when the gene is 
repressed. According with the above-mentioned RT-qPCR 
data, these ChIP results support the existence of different 
mechanism by which PARP-1 regulates c-fos and c-myc gene 
expression during the early phase of cell cycle reactivation. 
 
                              
 
                                 
 
 
Figure 6.  PARP-1 occupies c-fos promoter during G0-G1 transition. 
A) Schematic representation of c-fos promoter. The PCR primers used in the 
subsequent ChIP assays are showed. SRE: serum responsive element. 
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B) PARP-1 ChIP assays on c-fos promoter region. Quiescent and serum 
stimulated fibroblasts were fixed at the indicated minutes after serum 
addition. Sonicated chromatin samples from these cells were 
immunoprecipitated with an antibody  to PARP-1. Then DNA extracted from 
the immunoprecipitated fractions were amplified by PCR with primers 
specific for the c-fos promoter. PCR analyses show the desired-size 
products. DNA sample lane descriptions are as follows;. Input: samples 
isolated from cell lysates prior to antibody pull down representing the internal 
positive control; No Ab: samples isolated after pull down with no antibody 
representing the aspecific-bound DNA; PARP-1: samples isolated after 
PARP-1 immunoprecipitation. 
 
PARP-1 contributes to c-myc repression during quiescence 
entry 
We observed that in quiescent cells c-myc promoter is 
occupied by PARP-1, while after mitogen stimulation the 
enzyme is released, in concomitance with the poly(ADP-
ribosyl)ation of the same region. Moreover Kim e colleagues 
have reported an in vitro model in which PARP-1, promotes 
transcriptional repression in a manner similar to histone H1 
while following activation and auto-poly(ADP-ribosyl)ation, 
PARP-1 detaches from chromatin, leading to decompaction 
and transcriptional activation (Kim et al., 2004). According to 
Kim’s model and in light of the results of our ChIP 
experiments on c-myc promoter, we hypothesized that PARP-1 
may have a role in suppressing c-myc expression during 
quiescence establishment. To verify this hypothesis we 
analysed the effects of overexpressing the enzyme in parp-1  -/- 
fibroblasts. 
At first we assessed if the knock-out cells can enter quiescence 
when serum-starved. The levels of G1 phase markers including 
cyclin D1 and c-myc were determined by western blot while 
the cell cycle distribution was analysed by FACS on propidium 
iodide-stained cells. As reported in Figure 7 A-B, fibroblasts 
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down-regulate cyclin D and c-myc during quiescence entry and 
accumulate in G0/G1 after 48h from serum withdrawal.  
Secondly, fibroblasts were transfected with an expression 
vector coding for PARP-1 enzyme. The overexpression of 
exogenous PARP-1 was verified by western blot. Then cells 
were serum starved and the kinetics of c-myc down-regulation 
was followed over the time by quantifying its coding RNA by 
RT-qPCR. PARP-1 overexpression did not affect the basal 
levels of c-myc in proliferating cell but accelerated c-myc 
decrease during quiescence entry indicating a possible 
involvement for PARP-1 in the repression of c-myc 
transcription (figure 7C). 
 
   
Figure 7.  Parp-1 contributes to c-myc repression during 
quiescence entry. 
Proliferating parp-1 -/- fibroblasts were serum starved to induce cell cycle 
arrest. 
A B
C
Hr
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A) Western blot analysis of proliferation markers at different hours from 
serum withdrawal. Tubulin represent the loading control. 
B) Flow cytometric analysis of DNA content. A proliferating population of 
fibroblasts shows the characteristics two-peak distribution (left). After 48 
hours in 0.2% serum cells accumulates in the G0/G1 peak (right). 
C) Western blot analysis of exogenous PARP-1 expression in knockout 
fibroblasts (left panel) and RT-qPCR quantization of c-myc mRNA levels 
(right panel). Fibroblasts were transfected with a vector for PARP-1 
expression under the control of CMV promoter (red lines) or the empty 
vector (blue lines). Forty-eight hours later, cells were shifted in 0.2% serum. 
RNA levels of c-myc were normalized on 18S. The horizontal axis values 
represent the hours post serum withdrawal. The vertical axis values 
represent the fold expression change respect to control T0 sample and the 
error bars represent the SEM of three replicates. 
PARP-1 activity is involved in muscle reserve-cell 
activation  
To highlight the possible role of PARP-1 in regulating 
quiescence in a stem cell type, we focused our attention on 
muscle satellite cells. They are quiescent mono-nucleated cells 
resident between myofibres and basal lamina (Armand et al., 
1983; Schultz, 1976) whose activation in response to 
hypertrophic stimuli or trauma is the first step of growth, 
repair, and maintenance of skeletal muscle (Grounds and  
Yablonka-Reuveni, 1993).   
To circumvent experimental difficulties deriving from an in 
vivo approach to study satellite cell quiescence, we took 
advantage of C2 myoblasts, a satellite-derived myoblast cell 
line. These cells represent a well described in vitro model 
system that recapitulates many of the functional properties of 
satellite cells. When cultured in low serum, they are able to 
undergo myogenic differentiation (Yaffe and Saxel 1977). By 
contrast, abolishing C2 myoblasts adhesion to substrate 
reversibly arrests their cell cycle. This condition leads to a 
quiescent, undifferentiated “reserve cell” state, which is 
characterized by the expression of satellite cell markers and by 
the repression of muscle regulatory factors. This state can be 
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reverted by restoring cell adhesion in the presence of growth 
factors (Sachidanandan et al., 2002; Sambasivan et al., 2008). 
To obtain a homogeneous population of quiescent reserve cells, 
proliferating C2 myoblasts were cultured in suspension in 
methylcellulose-containing growth medium for 48 hours. We 
performed experiments in which gene expression of quiescent 
and activated reserve cells was assessed by RT-qPCR and 
western blot. As expected, in absence of substrate adhesion, 
reserve cells expressed no S-phase markers such as cyclin A, 
indicating the cell cycle withdrawal, and no detectable levels of 
the c-myc and c-fos IEG mRNA (Figure 8). Furthermore, the 
expression of the key muscle regulator MyoD was suppressed 
at both protein and RNA levels (Figure 8C-D) indicating that 
cell cycle arrest is uncoupled from differentiation in this 
condition.  
To establish whether restoring the adhesive contacts resulted in 
their activation, reserve cells were re-plated in growth medium 
after methylcellulose removal. The fast up-regulation of c-myc 
and c-fos, detected by RT-qPCR, indicated their cell cycle re-
entry. Moreover western blot analysis of cyclin A showed that 
these cells can resume proliferation. Indeed this S-phase 
marker was re-expressed within 20h from plating (Figure 8D). 
Importantly cells not only rapidly up-regulated the IEGs but 
also restored MyoD expression, as reported by RT-qPCR and 
western blot in Figure 8 C-D. 
The absence of MyoD in quiescent cells and its subsequent 
induction during cell cycle re-entry is consistent with the fact 
that these cells represent a suitable model for studying the 
activation of muscle satellite cells. 
To determine the possible implication for PARP activity in cell 
cycle re-entry of satellite cells, firstly we evaluated whether the 
PAR levels were modulated upon adhesion-dependent reserve 
cell activation. By performing a western blot analysis we found 
that PAR, indicative of PARP-activity, was almost 
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undetectable in G0 quiescent cells, while rapidly accumulated 
within 2 hours upon cell cycle re-entry (Figure 9A). 
 
 
 
 
 
 
Figure 8.  reserve cell activation. 
C2 myoblasts were arrested in G0 through suspension culture in methyl-
cellulose containing medium to induce the “reserve cell” state. Then cells 
were re-activated by replating in tissue culture dishes. Samples were 
collected at the indicated hours after replating. 
A-C) RT-qPCR quantization of c-myc, c-fos and MyoD. RNA levels are 
represented as  mean fold changes respect to control T0 sample and the 
error bars represent the SEM of three replicates. The horizontal axis values 
represent the hours post replatinig . 18S and L34 were used as normalizing 
genes. 
 D) Western blot analysis of MyoD and cyclin A protein levels in proliferating 
myoblasts (P), quiescent (0) and reactivated reserve cells at the indicated 
hours after replating. Ponceau staining of nitrocellulose membrane was used 
as loading control.  
A B 
D C 
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Secondly, we analysed the effects of the enzyme inhibition on 
the S-phase entry kinetics. Cells were re-activated in the 
presence or in the absence of the PARP inhibitor PJ-34 and 
DNA synthesis was monitored by BrdU labelling. As 
aforementioned reserve cells synchronized in quiescence by 
suspension re-entered S phase in an adhesion dependent 
manner. However, the addition of PJ-34 impaired the 
progression to S phase (Figure 9B). Moreover by performing 
RT-qPCR analysis, we examined also the effect of PARP 
inhibition on c-myc and MyoD expression. As shown in Figure 
9C, PJ-34 treatment impaired the up-regulation of both genes. 
Taken together these observations indicate that the activation 
of reserve cells requires PARP activity.  
To Assess the contribution of PARP-1 enzyme in the activation 
of reserve cells we analysed the effects of its knockdown on 
IEGs and myogenic regulatory factors. Mouse myoblasts were 
transduced with a retroviral construct expressing a specific 
shRNA designed to reduce PARP-1 expression (Figure 10A) or 
a control vector. Then cells were cultured in suspension to 
induce the quiescent reserve cell state and, after 48h, were 
reactivated by re-plating in growth medium. 
The western blots reported in Figure 10B show that the 
reduction of PARP-1 levels was associated with a significant 
inhibition of c-Myc and MyoD protein accumulation during 
cell cycle entry. Furthermore the response of c-myc and c-fos 
genes was analysed by RT-qPCR. As in fibroblasts, in the case 
of myoblast reserve cells PARP-1 knock-down impaired the 
induction of the two genes (Figure 10D). Taken together these 
data suggest the importance of PARP-1 in the re-activation of 
muscle reserve cells. 
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Figure 9  PARP activity is required for reserve cell activation. 
C2 myoblasts were arrested in G0 through suspension culture in methyl-
cellulose containing medium to induce the “reserve cell” state. Then the cells 
were re-activated by replating in tissue culture dishes in the presence or in 
the absence of PARP-1 inhibitor PJ-34. Samples were collected at the 
indicated hours after activation. 
A) western blot analysis of PAR accumulation in reserve cells during their 
activation. PAR level peaks two hours post cells plating. 
B) S phase entry kinetics. Percentage of BrdU-positive nuclei on total DAPI-
stained nuclei. Cells was activated in the absence (Blue rectangles) or in the 
presence of the PARP inhibitor PJ-34 (red rectangles) and fixed for 
immunostaining at the indicated hours (horizontal values). At least 400 
nuclei were counted for each sample and the results are the mean of three 
experiments. 
C) RT-qPCR quantization of c-myc and MyoD RNAs induction during 
reserve cell activation. Untreated samples are represented in violet or green, 
PJ-34 treated samples are reported in the light respective colours. On the 
horizontal axis the hours post cell activation are reported. The vertical axis 
values represent the mean fold changes respect to T0 sample and the error 
bars represent the SEM of three replicates. Target mRNAs are normalized 
on 18S and L34 levels. 
A 
B 
C 
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Figure 10. PARP-1 is implicated in reserve cell activation. 
A) Schematic representation of the retroviral construct used to silence 
PARP-1 expression. 
B) Western Blot analysis of PARP-1, c-Myc and MyoD in myoblasts infected 
with a retrovirus encoding for a shRNA specific for PARP-1 (shPARP-1) or 
with the empty vector (Empty). Samples were collected at the indicated time 
after adhesion-dependent reactivation of reserve cells. Comassie staining 
represents the loading control. 
C) Densitometry quantification of the c-Myc and MyoD protein level of the 
western blot reported in B. Vertical axis values represent the fold expression 
changes respect to each T0 sample. 
D) Myoblasts expressing the ShRNA direct against PARP-1 (red lines) or no 
shRNA (blue lines) were growth arrested and then reactivated. RNA levels of 
c-myc and c-fos were normalized on 18S and L34 and reported as fold 
D 
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changes respect to control T0 sample. The error bars represent the SEM of 
three replicates The horizontal axis values represent the minutes after cell 
plating. 
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DISCUSSION 
 
An increasing number of evidence from literature demonstrated 
that PARP-1, originally characterized as a key factor in DNA 
repair pathways, has a role in the regulation of gene expression 
and cell cycle progression. Specifically, PARP-1 can act as an 
integral part of cellular signaling pathways that culminate in 
gene-regulatory outcomes (D’Amours et al., 1999). 
Even though the best established functions of PARPs during 
cell cycle concern the control of chromosome segregation at 
mitosis, other reports indicate that these enzymes, particularly 
PARP-1, are involved in regulating cell cycle progression to 
other phases. PARP-1 acts at the S phase, both by participating 
in a multiprotein DNA replication complex (Simbulan-
Rosenthal et al., 1996) and by acting as a positive regulator of 
E2F1-mediated transcription and, hence, of S-phase gene 
expression (Simbulan-Rosenthal et al., 1999, 2003). Moreover, 
previous evidence correlated increased PARP expression and 
activity with liver regeneration (Cesarone et al., 1990), PBMC 
activation (Menegazzi et al., 1992) and thymocyte proliferation 
(Wein et al., 1993), but the role of PARPs in cell cycle re-entry 
was not further investigated. 
Our group previously highlighted a functional link between 
PARP-1 activation and fibroblast cell cycle re-entry (Carbone 
et al., 2008). In this work it was shown that increased 
poly(ADP-ribosyl)ation is transiently detectable after serum 
stimulation of quiescent fibroblasts and that PARP-1 is 
responsible for the most cellular poly(ADP-ribosyl)ating 
activity during the early response. More importantly inhibition 
of PARP activity by a competitive inhibitor named PJ-34 
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causes a dose-dependent interference with cell cycle 
reactivation. Analysis of the early phases of the response to 
serum stimulation revealed that PARP-1 activation correlates 
with and is required for the timely up-regulation of IEGs. 
Once demonstrated that PARP-1 activity is stimulated by 
mitogen treatment of resting fibroblasts and contributes to G0-
G1 transition through the induction of IEGs, we investigated 
how PARP-1 may regulate these genes.  
At first, the specific silencing of PARP-1 in quiescent 
fibroblasts confirmed that this enzyme is the PARP family 
member playing the most prominent role in IEGs activation 
and that this regulation occurs at the RNA level. 
Recent studies have revealed the role of PARP-1 in distinct 
ways of transcriptional regulation: this protein can act as an 
enhancer-binding factor, can function as a transcriptional 
coregulator and can play a role in the maintenance of insulator 
function (Kraus 2008). Further, PARP-1 can modulate the 
chromatin structure by binding to nucleosomes, modifying 
histone proteins or regulating the composition of chromatin.  
To go inside into potential molecular mechanisms by which 
PARP activity may acts locally on IEGs promoters regulation 
we focused our attention on c-myc promoter. All crucial 
aspects of cell proliferation, cell growth, and tumorigenesis are 
positively regulated by c-Myc. Consequently, the fine 
regulation of c-Myc expression is essential for normal cell 
function. Such a tight control is achieved through a regulation 
at multiple levels: transcription initiation and elongation, 
translation, mRNA and protein stability and post translational 
modification and interacting proteins. Besides, chromatin 
remodeling provides an important additional level for control 
(Wierstra and Alves, 2008).  
C-myc gene is transcribed from the dual P1 and P2 promoters 
(located 160 bp apart), with a dominance of P2. Moreover, the 
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nucleosomal structure of this promoter region undergoes a 
reversible change after gene activation (reviewed by Wierstra 
and Alves, 2008). To elucidate the mechanism by which 
PARP-1 may regulate transcription locally, we performed a 
DNAse accessibility assay, in the presence or in absence of 
PARP activity. Generally, the differential sensitivity to 
DNAseI has been identified as a characteristic feature that 
distinguishes the chromatin of transcribed and silent genes and 
is presumed to reflect alterations of factor binding, nucleosome 
positioning, or DNA conformation (Levens et al., 1997; Liu 
and Levens, 2006). Specifically, we observed that after serum 
stimulation of quiescence fibroblasts the chromatin of c-myc 
domain including P1 and P2 promoters undergoes a structural 
change, from a closed and transcriptionally inactive state to an 
expanded and transcription factor-accessible state, in a PARP-
activity dependent manner. Thus, the DNAse accessibility 
assay of c-myc promoter gave us the first demonstration of a 
local involvement of PARP activity in causing chromatin to 
expand and indicated poly(ADP-ribosyl)ation as a specific 
epigenetic mark for c-myc regulation during G0-G1 transition.  
A link between epigenetics and PARPs should not have come 
as a surprise, since poly(ADP-ribosyl)ation of histone proteins 
has long been associated with an extended and open chromatin 
conformation believed to facilitate the access of DNA repair 
factors to the damage chromatin (D’Amours et al., 1999). The 
first evidence for the implication of PARP activity in 
chromatin loosening comes from the study of hsp70 gene 
activation in Drosophila larval salivary glands. In this work the 
authors have shown that  poly(ADP-ribosyl)ation is required to 
produce polytene chromosome puff formations associated with 
gene induction (Tulin and Spradling, 2003). Indeed, it’s well 
established that histones are amongst the main substrates and 
that poly(ADP-ribosyl)ation of these building blocks of the 
nucleosome reduces their affinity to DNA thereby increasing 
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the accessibility of the chromatin fibre. On the basis of this 
evidence, we can suppose several mechanisms by which 
PARP-1 could affect the condensation status of chromatin at c-
myc promoter and the accessibility to transcription: The most 
obvious would be the direct modification of  chromatin 
structural proteins or transcription regulatory factors. 
Unfortunately this case cannot be directly verified at the 
moment since specific antibodies for poly(ADP-ribosyl)ated 
proteins to be used in ChIP assays are not yet available.  
To further study the effects of PARP activity on c-myc 
regulation we analysed its promoter occupancy by two 
transcription factors. CTCF and Sp1 are known to be negative 
and positive regulators of c-myc gene, respectively (Filippova 
et al., 1996; Majello et al., 1995). Consistently we found that 
during quiescence CTCF but not Sp1 is present on c-myc 
promoter. Moreover after serum stimulation, CTCF is 
displaced while Sp1 is recruited on its regulatory region. 
Interestingly, the inhibition of PARP activation by PJ-34 
treatment of stimulated cells restores the promoter state 
occupancy of the quiescence, for both transcription factors. 
These results are consistent with the DNAse accessibility assay 
experiment, suggesting a role for poly(ADP-ribosyl)ation in 
mediating the switch of CTCF and Sp1 at the promoter. 
Moreover, we found that PARP-1 coimmunoprecipitates with 
c-myc promoter chromatin in quiescent cells, that virtually do 
not express c-myc. In contrast cell cycle re-activation by serum 
stimulation causes PARP-1 promoter detachment, probably due 
to its automodification, and the poly(ADP-ribosyl)ation of the 
same region. This local poly(ADP-ribosyl)ation is related with 
the exchange of specific transcription factors on c-myc 
promoter. In addition, PARP-1 is not detected on c-myc 
promoter in proliferating cells when the gene is expressed at a 
basal level.  
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The finding that PARP-1 binds to c-myc promoter during the 
quiescent state prompted us to study the effects of the enzyme 
knock-down at different times in relation to growth arrest. 
Unexpectedly PARP-1 silencing, performed before cell cycle 
exit, does not significantly influence c-myc expression. In 
addition parp-1-/- cells correctly enter and exit the quiescence 
state suggesting that the PARP-1 dependent mechanism of c-
myc gene regulation have to be established before quiescence 
entry. Hence if the enzyme is already absent in proliferating 
cells, c-myc up-regulation during G0-G1 transition could occur 
in a PARP-1 independent manner, involving other chromatine-
related mechanisms or perhaps another member of the PARP 
family. 
On the basis of this dynamics of PARP-1 binding and activity 
to c-myc promoter we hypothesized a possible mechanism 
involving an active participation of the enzyme first in the 
repression, when cells have to exit cell cycle, and then in de-
repression when cells have to be reactivated. This dual role 
would be supported by a well established in vitro model in 
which in the absence of NAD+ PARP-1, by binding to 
nucleosomes, promotes chromatin compaction and 
transcriptional repression in a manner similar to histone H1. 
Following activation and auto-poly(ADP-ribosyl)ation in the 
presence of NAD+, PARP-1 detaches from chromatin, leading 
to decompaction and transcriptional activation (Kim et al., 
2004). Accordingly the overexpression experiments in parp-1-
/- fibroblasts showed that exogenous PARP-1 accelerates c-
myc shutdown during the establishment of quiescence without 
affecting the basal levels of c-myc expression in proliferating 
cell. These data suggest a possible implication for PARP-1 in 
the repression of c-myc transcription during quiescence. 
PARP-1, still not activated, either by itself or by regulating 
other chromatin modifiers may induce chromatin condensation 
or may promote CTCF inhibitory effects on c-myc. At the 
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same time, PARP-1, CTCF or the presence of both may 
prevent Sp1 binding to c-myc promoter. Therefore, 15 min post 
stimulation PARP-1, now automodified, detaches from the 
promoter facilitating CTCF removal (either by direct 
interaction with the factor or by its poly(ADP-ribosyl)ation). 
Furthermore PARP-1 activity causes chromatin relaxation. In 
this condition Sp1 and possibly other transcriptional factors 
may interact with their binding sequences acting as a positive 
transcription regulators. Collectively our data reveal a 
functional link between promoter binding and gene-regulatory 
actions of PARP-1, highlighting the relation between PARP-1 
activity and the function of transcription factors (Figure 11).  
In any case, we cannot exclude the participation of additional 
mechanisms that could mediate the PARP-1-dependent 
changes at IEG promoters. For example, it has been reported 
that PARP-1 interacts with co-repressor and co-activator 
complexes which contain histone deacetylases and acetylases 
(Ju et al., 2004; Ju et al., 2006) and more recently, with the 
histone demethylase KDM5B (Krishnakumar and Kraus, 
2010a). Additional studies are needed to clarify this specific 
mechanism. ChIP specific for histone modifications or 
transcriptional factors and cofactors could be helpful for this 
purpose.  
The IEGs expression data from the PARP-1 knock-down 
experiments performed at different times during growth arrest 
in addition to ChIP assay results, suggest some differences 
between PARP-1 dependent regulation of c-myc and c-fos 
promoters. Certainly PARP-1 knock-down, performed in 
fibroblasts after growth arrest, affects c-myc as well c-fos 
serum-induced up-regulation. Otherwise, when the enzyme was 
silenced before quiescence establishment, only the induction of 
c-fos was significantly affected. Moreover differently from 
what happens for c-myc whose promoter binds PARP-1 in 
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Figure11. Proposed model of PARP-1 action at c-myc promoter 
During quiescence PARP-1 binds to c-myc promoter favouring shut off of the 
gene. The enzyme could induce chromatin compaction or recruit repressive 
factors (RF). After mitogenic stimulation active PARP-1 poly(ADP-
ribosyl)ates the promoter and detaches from it allowing chromatin de-
condensation and transcriptional factor (TF) exchanges.  
 
quiescence and is released in concomitance with the induction, 
PARP-1 coimmunoprecipitates with active c-fos promoter after 
serum stimulation but not during quiescence when the gene is 
repressed. These data suggest that PARP-1 is implicated in the 
prompt induction of c-fos at the early phase of G0 exit but, 
unlike for c-myc, not for the repression of the gene. This is not 
completely unexpected because the promoters of the two IEGs 
are quite different (reviewed by Wierstra and Alves, 2008 ; 
Janknecht at al.,1995 ) as well as their patterns of expression 
show some differences. In fact after a rapid induction 
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promoting G0/G1 transition, c‐myc mRNA declines to a 
lower level which persists during the whole cell cycle (in 
continuously proliferating cells) while c-fos mRNA drop to 
under detectable levels also in cycling cells except that other 
signals e.g cytokines, ionizing radiation and stress cause its 
induction. 
 To identify a specific roles of PARP-1 in the reversible 
transitions between quiescence and proliferation in a other 
cellular system the attention was focused on muscle satellite 
cells, which are quiescent mono-nucleated cells resident 
between myofibres and basal lamina (Armand et al., 1983; 
Schultz, 1976). The experimental in vivo approach  to study the 
satellite cell quiescence raises several difficulties not only 
because these cells represent  a very small population, but also 
because every method for isolating them inevitably leads to 
their activation. However, there are some reliable in vitro 
model systems that recapitulate many of the functional 
properties of satellite cells and allow the generation of 
homogenous cell populations that can be reversibly arrested in 
G0. C2 myoblasts, a satellite-derived myoblast cell line (Yaffe 
and Saxel 1977), when cultured in low serum, are able to 
undergo a well characterized process of differentiation that 
recapitulates many features of in vivo myogenesis. A 
subpopulation present in differentiated C2 cell cultures 
showing many properties of satellite cells is known as C2 
myoblast-derived “reserve cells” (Kitzmann et al., 1998; 
Yoshida et al., 1998). In particular, they are in a quiescent 
state, have lost the expression of muscle regulatory factors and 
retain the myogenic potential. When stimulated by serum, 
“reserve cells” proliferate, re-express myogenic factors and can 
be induced to differentiation, producing myofibers and once 
again quiescent reserve cells. In addition, C2 myoblasts can be 
arrested in G0 through suspension culture in methyl-cellulose. 
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This condition also leads to an “reserve cell-like” 
undifferentiated state, which is characterized by growth arrest, 
expression of satellite cell markers and down-regulation of 
myogenic determinants (Sachidanandan et al., 2002; 
Sambasivan et al., 2008).  
We investigated PARP-1 involvement in the reactivation of 
satellite cells using the C2 myoblasts model system 
synchronized in G0 (“reserve cell-like” state) by suspension in 
a viscous gel of methylcellulose-containing media and then 
reactivated by restoring cell anchorage. Our results suggest that 
poly(ADP-ribosyl)ation may regulate quiescence even in 
satellite cells. Western blot analysis of cell extracts from 
methyl-cellulose- synchronized myoblasts shows that 
poly(ADP-ribose), indicative of PARP-activity, rapidly 
accumulates within 2 hours upon cell cycle re-entry. 
Interestingly, PARP activation precedes the induction of c-
myc, just like in mitogen-stimulated fibroblasts. Most 
importantly, the inhibition of the enzyme activity impairs c-
myc and MyoD up-regulation and prevents S-phase entry. 
These observations suggest that the importance of PARP 
activity in the emergence from quiescence could be also 
extended to the function of muscle stem cells. 
In conclusion in this work we highlight a role of PARP-1 in the 
regulation of cell quiescence which is of fundamental 
importance for controlling differentiation, preserving stem cell 
function and preventing tumorigenesis. The identification of 
new mechanisms involved in the transitions between 
quiescence and proliferation will provide valuable information 
aimed at devising further strategies for cancer treatment or for 
a controlled stem cells proliferation. 
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MATERIALS AND METHODS 
 
Cell culture  
Mouse embryonic fibroblasts (MEF), mouse embryonic 
fibroblasts from PARP-/- mice (A1) and human fibroblasts 
were grown in Dulbecco's Modified Eagle Medium (DMEM) 
(Gibco-BRL) supplemented with 10% fetal bovine serum 
(FBS, Cambrex), 2 mM L-glutamine, 1% pen/strep solution 
(v/v). For serum stimulation experiments, fibroblasts were 
grown for 48 hours in DMEM containing 0.2% FBS and then 
stimulated by incubation in growth culture medium 
supplemented with 10% FBS. When indicated PJ-34 (Sigma-
Aldrich) previously diluted in aqueous solution was added at 
the final concentration of 30µM. 
C2C12 mouse myoblasts were passaged and maintained as 
subconfluent monolayers in growth medium, high glucose 
DMEM (GIBCO) supplemented with 20% FBS. To growth 
arrest myoblasts, cultures were trypsinized and suspended at a 
final density of 2 x l0^5 cells per ml in DMEM containing 
1.3% Methocel (SIGMA), supplemented with 10% FBS. After 
72h, suspended cells were recovered for replating by dilution 
of methylcellulose-containing medium with four volumes of 
sterile phosphate-buffered saline (PBS) followed by 
centrifugation at 2000 g, 30 minutes, room temperature. the 
cells were replated on tissue culture dishes in growth medium 
(10% FBS) and analysed at the indicated times following 
replating (Milasincic et al., 1996). When indicated PJ-34 
(Sigma-Aldrich) previously diluted in aqueous solution was 
added to the growth medium at the final concentration of 
30µM. 
 45 
 
Flow cytometric analysis of DNA content  
Fibroblasts were trypsinized and counted. 5x 10^5 cells were 
fixed in 70% ethanol for 16 hours incubated with 0.1 mg/ml 
Propidium Iodide (Sigma-Aldrich) and 2 mg/ml RNAse in PBS 
for 30’ in the dark. Cell cycle profiles of stained cells were 
obtained by flow cytometric analysis with FACS Calibur (BD 
Bioscience Pharmingen). 
Immunofluorescence analysis of BrdU incorporation 
Cells were first incubated for the indicated periods of time with 
20uM bromodeoxyuridine (BrdU) and then fixed with 30% 
methanol/70% acetone for 30 min at -20°C. Cells were treated 
with 1.5M HCl for 30 min at room temperature. After washing 
three times with PBS, cells were incubated with anti BrdU 
antibody (sc-51514 Santa Cruz biotechnology) 1:50 in 3% 
BSA/PBS for 1 hour. After that, cells were washed three times 
with PBS and incubated for 45 minutes in the dark with a 
rodaminated goat anti-mouse antibody (dilution 1:100 in 3% 
BSA/PBS.) Then the cells were rinsed with PBS. To 
counterstain nuclei, cells were incubated with DAPI for 5 min 
at room temperature. immunostained cells were analysed on 
Nikon microphot FXA equipped with a 20x objective. 
RNA interference and overexpression 
For PARP-1 siRNA experiments in quiescent cells, MEF cells 
(2.5×10^5cells) were grown for 36h in DMEM containing 
0.2% FBS and then transfected with a mix containing 20µl of 
Lipofectamine 2000 reagent (Invitrogen Life Science 
Technologies, CA, USA) plus 150nM of siRNA oligos. At 48h 
after cells were stimulated by incubation in DMEM with 10% 
FBS and collected for RNA or protein analysis.  
For siRNA experiments in proliferating cells, MEF were 
seeded in DMEM containing 10% FBS 16h before transfection. 
24h after transfection growth medium was replaced with 
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DMEM containing 0.2% FBS. After 48h cells were stimulated 
by incubation in DMEM with 10% FBS and collected for RNA 
or protein analysis 
siRNA target sequences: 
parp-1 5’-TAAAGAAGCTGACGGTGAA-3’ 
gfp   5’-GGCTACGTCCAGGAGCGCACC-3’ 
 
A1 fibroblasts were transfected with pPARP31 plasmid DNA 
containing the full length cDNA sequence of PARP-1 or the 
empty vector as a control and Lipofectamine 2000 reagent 
according to manufacturer’s At 48 h after transfection, the 
growth medium (10% FBS) was replaced by fresh medium 
containing 0.2% FBS to induce growth arrest. PARR-1 
expression was assessed by western blot 48h after transfection. 
Retrovirus production and infection 
We designed 3 hairpins targeting PARP-1 gene. Of these, we 
successfully cloned 2 hairpins. These hairpins were cloned into 
a retroviral vector (LMP from Open Biosystem) containing a 
puromycin resistance gene and GFP gene as a marker for 
retroviral integration. Briefly, synthetic double-stranded oligos 
that represent a stem-loop hairpin structure were PCR 
amplificated and cloned into retroviral vector. the expression of 
a given hairpin produces a shRNA that targets the gene of 
interest. To obtain high titer recombinant retroviruses 
expressing, the BOSC 23 packaging cells were transfected with 
LMP-shPARP-1 as previously described (Fimia et al., 1998). 
Briefly, 6×10^6 cells were seeded onto 100-mm tissue culture 
dishes in DMEM supplemented with 10% FBS and grown for 
24 h. Just before transfection, 25 µM chloroquine was added to 
the culture medium and 20 µg of plasmid/100-mm dish were 
transfected with the calcium phosphate precipitation method. 
After 10 h the medium was changed and cells were incubated 
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for an additional 16 h in DMEM-10% FBS. Medium was again 
replaced with a smaller volume. The retroviral supernatant was 
harvested 24 h later and, after removal of cell debris, frozen at 
−80°C for later use. BOSC 23 retroviral supernatants were 
routinely tested for their ability to infect the cells, by 
immunofluorescence detection of GFP expression. For 
retroviral infections, cells were plated 24 h before infection 
then they were incubated with the specific BOSC 23 retroviral 
supernatant supplemented with 4 µg/ml polybrene for 8 h and 
then re-fed with fresh medium. The effect of ShRNA 
expression was assessed 48h after transduction with western 
blot analysis of PARP-1 protein levels. 
Real Time-PCR  
Total cellular RNA was extracted with “High Pure RNA 
Isolation Kit” according to the manufacturer’s instructions 
(Roche Diagnostics). 1 µg of total RNA was reverse 
transcribed (Iscript cDNA Synthesis Kit, bio-rad). Real 
timePCR reaction was performed in 20 µl of reaction buffer 
containing 1µl of diluted cDNA, 10 µl of  GoTaq qPCR Master 
Mix (Promega) and each primer at the optimized final 
concentration (150-250nM). The reaction was performed in the 
termocycler “MiniOpticon Real-Time PCR detection system” 
(Bio-Rad). The primer pair efficiency, the normalized 
expressions (∆∆C(t)) and the Standard Deviation for the 
Normalized Expression were determined with CFX 
ManagerTM software (Bio-Rad). 
Gene Accession 
number 
Primer set 
c-myc NM_001177354 5’-TGCCCGCGATCAGCTCTCCT-3’ 
5’-GGGGCATCGTCGTGGCTGTC-3’ 
c-fos NM_010234 5’-AGGGCAGCAGCAGCAACGAG-3’ 
5’-CTCGGGCAGTGGCACGTCTG-3’ 
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junb NM_008416.3 5’-ACGACTCTTACGCAGCGGCG-3’ 
5’-GCCAGGTTGAGCGCCAAGGT-3’ 
parp-1 NM_007415 5’-GCGAGGTCCAGCAGGCAGTG-3’ 
5’-ACCTTGGCCTGCACGCTGTC-3’ 
myod NM_010866 5’-CTCTGCTGCGCGACCAGGAC-3’ 
5’-GGGCCGCTGTAATCCATCATGCC-3’ 
18s NR_003278 5’-ACGACCCATTCGAACGTCTG-3’ 
5’-GCACGGCGACTACCATCG-3’ 
L34 NM_053162 5’-GGA GCC CCA TCC AGA CTC-3’ 
5’-CGC TGG ATA TGG CTT TCC TA-3’ 
Western blot 
For western blot analysis cells were washed twice with cold 
PBS and lysed in Leamli 1x. Proteins were resolved by 
electrophoresis in 8%-10% SDS-PAGE and transferred to 
nitrocellulose membranes by electro-blotting. Membranes were 
blocked in 1% non-fat dry milk in TBS containing 0.05% 
Tween 20 for 1h at room temperature and incubated with 
primary antibody overnight at 4°C, then membranes were 
washed three times and incubated in a 1:10000 or 1:20000 
dilution peroxidase-conjugated anti-mouse or anti-rabbit 
respectively (Bio-Rad). Proteins were detected using the ECL 
chemiluminescence system (Pierce). 
The following primary antibodies used for western blot were 
purchased from Santa Cruz Biotechnology: c-Myc N-262 (sc-
764); c-Fos 4 (sc-52); PARP-1 H-250 (sc-7150), cyclin A(C-
19)sc-596, cyclin D1 72-13G (sc-450) and α-Tubulin TU-02 
(sc-8035).  
The following primary antibodies used for western blot were 
purchased from Enzo biochem: anti-PAR (H-10), monoclonal 
anti-PARP-1 (C2-10 and F1-23), polyclonal anti-PARP-1, 
MyoD1 clone 5.8A from Dako 
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Chromatin immunoprecipitation (ChIP) 
Cells were treated with formaldehyde (1% final concentration), 
added directly to the culture dishes, to cross-link protein 
complexes to the DNA. The reaction was stopped by adding 
glycine to a final concentration of 0.125M for 5 min at RT. 
Cells were washed with cold phosphate buffered saline, 
scraped and lysed in L1 buffer (2mM EDTA, 50mM Tris-HCl 
[pH8.1], 0.1% NP40, 10% Glicerol and protease and 
phosphatase inhibitors) for 20 min at 4°C in rotation. The 
lysates were homogenized by and then centrifuged at 5000 rpm 
for 5 min at 4°C. Nuclear pellets were resuspended in L2 buffer 
(5mM EDTA, 50mM Tris-HCl (pH8.0), SDS 1% and protease 
and phosphatase inhibitors) and kept on ice for 10 min. Nuclear 
lysates were sonicated to obtain chromatin fragments of an 
average length of 200 to 800 bp and centrifuged at 10000 rpm 
for 10 min at 4°C. The sonicated supernatant fractions were 
diluted 10 fold with dilution buffer (5mM EDTA, 50mM Tris-
HCl (pH8.0), NP40 0.5%, NaCl 200 mM and protease and 
phosphatase inhibitors). After determining the DNA 
concentrations, each chromatin sample was divided into 
aliquots of 100µg of chromatin was incubated with Protein A 
or G Sepharose for 3 hours at 4°C on a rotating platform. The 
beads was pre-incubated with BSA and Salmon sperm O.N.. 
The pre-cleared chromatin samples were centrifuged at 14,000 
rpm for 5 min and incubated with antibody or without antibody 
overnight with gently rotation at 4°C. Before washing, an 
aliquot of  the supernatant of the no antibody control was taken 
as input sample. After the immunoprecipitate was washed 
twice with a low salt wash buffer (0.1% SDS, 1% triton X-100, 
2mM EDTA, 20mMTris-HCl, pH 8.1, 150mM Nacl), twice 
with high salt wash buffer ( 0.1% SDS, 1% triton X-100, 2mM 
EDTA, 20mMTris-HCl, pH 8.1, 500 mM Nacl) ant with LiCl 
wash buffer (0.25M LiCl, 1% NP40, 1% deoxycholate, 
1mMEDTA, 10mM Tris-HCl, pH 8.1) supplemented with 
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protease and phosphatase inhibitors. Pellets were dissolved in 
300 µl elution buffer (1% SDS, 0.1 M NaHCO3). The samples 
treated with RNAse A for 10 min at RT were incubated at 67 
°C  overnight to reverse the protein-DNA cross-linking. Then 
in each sample the NaHCO3 was neutralized with 6 µl Tris-
HCl 1M (pH6-7.5). After treatment with proteinase K, the 
DNA was extracted with phenol-chloroform, precipitated with 
ethanol and resuspendend in 200 µl of distilled water. 1 µl of 
immunoprecipitated were used for PCR. 
The following antibodies were used for immunoprecipitation: 
Sp-1 (sc-59) from Santa Cruz Biotechnology, CTCF (07-729) 
from Millipore, PARP-1 (pAb 210-302 R100) from Alexis 
biochemical, PAR (H 10) from Enzo biochem. 
c-myc promoter 
Left primer 5’-CTTTAAATGCGAGGGTCTGG-3’ 
Right primer 5’-TGCCTCTCGCTGGAATTACT-3’ 
DNaseI accessibility assay. 
Quiescent or serum stimulated cells were rinsed with PBS and 
then with ice-cold CSK buffer (10 mM HEPES [pH 7.4], 300 
mM sucrose, 100 mM NaCl, 3 mM MgCl2). Cells were 
scraped from the plate, pelleted by centrifugation at 3000 rpm, 
and lysed in CSK-Triton buffer (CSK buffer containing 0.5% 
Triton X-100, 1 µg of leupeptin/ml, 1 µg of aprotinin/ml, 1 
mM NaF, 1 mM Na3VO4, and 1 mM phenylmethylsulfonyl 
fluoride) at 10^7 cells/ml for 10 min on ice. Nuclei were 
pelleted by centrifugation at 3000 rpm for 5 min at 4°C. 
Supernatants  were removed. The pelleted nuclei then were 
washed with 1 ml of CSK-Triton buffer, pelleted by 
centrifugation, and suspended in CSK-Triton buffer containing  
DNase I (0-100 U) and 50 mM MgCl2 and incubated on ice for 
4 min. the digestion was stopped with 9 volumes of DNA lysis 
Buffer( Tris 10 mM, EDTA 10mM e 0.5% SDS). The samples 
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were treated with proteinase K for 2 hours 56°C. then the DNA 
was extracted with phenol-chloroform, precipitated with 
ethanol and resuspendend in 500 µl of distilled water. 2 µl of  
DNA  samples were used for PCR. 
c-myc promoter  NG_007161 
Left primer 5’-GAGGAGCAGCAGAGAAAGG-3’ 
Right primer 5’-TCCAGCGTCTAAGCAGCTGCAA-3’ 
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